Association of Insulin Resistance Indexes to Carotid Intima-Media Thickness

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Sciacqua, Angela ^a   Marini, Maria Adelaide ^b   Hribal, Marta Letizia ^a   Perticone, Francesco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD VESSEL INJURY; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT INDEX; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER INSULIN RESISTANCE INDEX; MALE; MATSUDA INDEX; MATSUDA2 INDEX; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; ORAL GLUCOSE INSULIN SENSITIVITY; ORAL GLUCOSE TOLERANCE TEST; RECEIVER OPERATING CHARACTERISTIC; STUMVOLL INSULIN SENSITIVITY INDEX; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD GLUCOSE; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; STATISTICS AS TOPIC;

EID: 84872260867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053968     Document Type: Article

References (28)

1. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, et al. (1996) Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93: 1809-1817.
2. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW, (2005) Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54: 3252-3257.
3. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM, San Antonio Heart Study, (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26: 3153-3159.
4. Reaven G, (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-607.
5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
6. Ford ES, (2005) Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28: 1769-1778.
7. Yip J, Facchini FS, Reaven GM, (1998) Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 83: 2773-2776.
8. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, et al. (1996) Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334: 952-957.
9. Hanley AJ, Williams K, Stern MP, Haffner SM, (2002) Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25: 1177-1184.
10. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, et al. (2004) DECODE Insulin Study Group: Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47: 1245-1256.
11. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, et al. (1996) Insulin sensitivity and atherosclerosis. Circulation 93: 1809-1817.
12. Cardellini M, Marini MA, Frontoni S, Hribal ML, Andreozzi F, et al. (2007) Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. Am J Physiol Endocrinol Metab 292: E347-352.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
14. Matsuda M, De Fronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
15. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295-301.
16. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001 A Model-Based Method for Assessing Insulin Sensitivity from the Oral Glucose Tolerance Test. Diabetes Care 24: 539-548.
17. Vangipurapu J, Stančáková A, Kuulasmaa T, Paananen J, Kuusisto J, et al. (2011) A novel surrogate index for hepatic insulin resistance. Diabetologia 54: 540-543.
18. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, et al. (1999) Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340: 14-22.
19. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, et al. (2007) Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non-obese women and obese insulin resistant women. Diabetes Care 30: 2145-2147.
20. Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, et al. (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207: 245-249.
21. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536.
22. DeLong ER, DeLong DM, Clarke-Pearson DL, (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
23. Sesti G, (2006) Pathophysiology of insulin resistance. Best Practice & Research Clinical Endocrinology & Metabolism 20: 665-679.
24. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA, (2007) Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94.
25. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, et al. (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106: 913-919.
26. Osborn O, Olefsky JM, (2012) The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18: 363-374.
27. Haffner SM, D'Agostino R Jr, Saad MF, Rewers M, Mykkänen L, et al. (1996) Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45: 742-748.
28. Haffner SM, Stern MP, Dunn J, Mobley M, Blackwell J, et al. (1990) Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism 39: 842-847.